Clinical Study to Evaluate of The Whitening Efficacy and Safety of REMEWHITE

A Randomized, Double-blind, Placebo-controlled Clinical Study to Evaluate of The Whitening Efficacy and Safety of REMEWHITE

Status

Completed

Phases

Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00978861

Acronym

REMEWHITE

Enrollment

Registered

2009-09-17

Start date

2008-10-31

Completion date

2009-08-31

Last updated

2009-09-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tooth Whitening

Brief summary

The purpose of this study is to determine the effect of REMEWHITE on tooth whitening.

Detailed description

This study intended to establish the efficacy of REMEWHITE after using the product under controlled conditions at the hospital. The efficacy of the product was assessed at the end of the study; clinical examination by the dentist.

Interventions

DRUGHydrogen Peroxide

Whitening product syringe type

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender

ALL

Age

20 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* ability to understand and provide informed consent * general good health male and female adults, were 20 years or older * no pregnant woman * had six caines-free maxillary anterior teeth without restorations on the labial surfaces

Exclusion criteria

* had severe internal discoloration (tetracycline stains, fluorosis, pulpless teeth) * evidence of fracture or major cracks on tooth * were pregnant or nursing * had tooth sensitivity * smokers * had teeth shade A1, A2

Design outcomes

Primary

Measure	Time frame
colorimeter	12 weeks after treatment

Secondary

Measure	Time frame
colorimeter	24 weeks after treatment

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026